Other OTC Pharmaceuticals (Pharmacies) - Costa Rica

  • Costa Rica
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$30.53m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.25%, resulting in a market volume of US$32.48m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$5.82 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Costa Rica is experiencing significant growth and development.

Customer preferences:
Costa Rican consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of purchasing these products without a prescription. Additionally, the increasing awareness and knowledge about self-care and preventive healthcare have also contributed to the rise in demand for OTC pharmaceuticals.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Costa Rica is the increasing demand for products related to personal care and wellness. Consumers are seeking products that cater to their specific needs, such as vitamins, supplements, and skincare products. This trend is driven by the growing focus on maintaining a healthy lifestyle and the desire for products that enhance overall well-being. Another trend in the market is the shift towards natural and herbal remedies. Costa Rican consumers are increasingly opting for products that are perceived to be more natural and have fewer side effects. This trend aligns with the global movement towards natural and organic products, as consumers become more conscious about the ingredients and potential health risks associated with traditional pharmaceuticals.

Local special circumstances:
Costa Rica has a well-established healthcare system, with a high level of access to healthcare services. However, there are certain limitations and challenges that contribute to the growth of the Other OTC Pharmaceuticals market. One of these challenges is the limited availability of prescription medications in public healthcare facilities, leading consumers to rely more on OTC pharmaceuticals for their healthcare needs. Additionally, the country's aging population is also driving the demand for OTC pharmaceuticals. As the population ages, there is a greater need for products that address age-related health concerns, such as joint pain, digestive issues, and cognitive health. This demographic shift is expected to further fuel the growth of the Other OTC Pharmaceuticals market in Costa Rica.

Underlying macroeconomic factors:
Costa Rica has experienced steady economic growth in recent years, which has contributed to the increasing purchasing power of consumers. This has allowed consumers to allocate a larger portion of their disposable income towards healthcare and wellness products, including OTC pharmaceuticals. Furthermore, the government of Costa Rica has implemented policies to promote the growth of the pharmaceutical industry, including the development of a regulatory framework that supports the sale and distribution of OTC pharmaceuticals. This has created a favorable business environment for both local and international pharmaceutical companies, leading to increased competition and product innovation in the market. In conclusion, the Other OTC Pharmaceuticals market in Costa Rica is developing due to the changing customer preferences, including the demand for personal care and wellness products, as well as the shift towards natural remedies. The local special circumstances, such as the limited availability of prescription medications and the aging population, further contribute to the growth of the market. Additionally, underlying macroeconomic factors, such as economic growth and government policies, play a significant role in driving the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)